AACR 2019: Single agent umbralisib effective for relapsed slow-growing lymphoma
A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug…
Browsing: PI3K inhibitors
A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug…